Proteome Sciences PLC 2022 AR2
The report outlines Proteome Sciences plc's financial and operational performance for the fiscal year ended December 31, 2022. The company achieved a 52% increase in Group revenues to £7.78m, driven by strong growth in both its proteomics services and TMT product sales. Proteome Sciences continued strategic investments in its workforce, adding six employees, and expanded its technological capabilities with the installation of the CellenONE single cell proteomics platform. Despite macroeconomic challenges, including inflation and supply chain disruptions, the company recorded an operating profit of £1.73m and increased its cash reserves to £3.99m.
Company: Proteome Sciences PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2022
Type: AR2
Pages: 91
Back to company
Proteome Sciences PLC
Report And Financial Statements
The report outlines Proteome Sciences plc's financial and operational performance for the fiscal year ended December 31, 2022. The company achieved a 52% increase in Group revenues to £7.78m, driven by strong growth in both its proteomics services and TMT product sales. Proteome Sciences continued strategic investments in its workforce, adding six employees, and expanded its technological capabilities with the installation of the CellenONE single cell proteomics platform. Despite macroeconomic challenges, including inflation and supply chain disruptions, the company recorded an operating profit of £1.73m and increased its cash reserves to £3.99m.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees